After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

The Down syndrome treatment market in the USA is valued at nearly $250 million, with companies like Aelis Farma, AC Immune, ...

The strain of opioid use disorder (OUD), a chronic neurological disorder characterized by the compulsive, repeated use of ...

Kelun-Biotech has received marketing authorization in China for sacituzumab tirumotecan (sac-TMT), a Trop2-directed ADC for ...

The Biden administration has proposed a new rule that could significantly expand Medicare and Medicaid coverage for obesity ...

AI-powered protein engineering company Cradle has raised $73 million in a Series B funding. The European firm, which has now ...

The US Food and Drug Administration (FDA) has extended the review period for Soleno Therapeutics’ the New Drug Application ...

Samsung Bioepis has appointed Kyung-Ah Kim as president and CEO, succeeding Christopher Hansung Ko. The leadership change ...

US clinical stage biotech Alector saw its shares tumble 35% to $2.57 by close of trading yesterday, as it announced ...

The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and stomach cancers. The approval, based on positive Phase III trial results, ...

Japanese drugmaker Otsuka has announced the submission of a New Drug Application (NDA) to the Japanese Ministry of Health, ...